Breaking News
January 22, 2019 - Better mouse model built to enable precision-medicine research for Alzheimer’s
January 22, 2019 - Molecular profiling of precancerous lung lesions could lead to early detection and new treatments
January 22, 2019 - Genetic factors influence where fat is stored in our bodies
January 22, 2019 - The Psychology Behind Sticking to Your New Year’s Resolutions
January 22, 2019 - Scientists aim to find genetic causes of developmental abnormalities in the vagina and uterus
January 22, 2019 - Looming Global Crisis Means People’s Diets Must Change: Experts
January 22, 2019 - Excessive social media use is comparable to drug addiction
January 22, 2019 - Researchers show how mechanical stress affects bone development
January 22, 2019 - Study takes a step closer to understanding the body’s response to opioid painkillers
January 22, 2019 - Unexpected connection found between feeding and memory centers of the brain
January 22, 2019 - A revolutionary approach transforms bone trauma treatment
January 22, 2019 - Early studies and recent clinical trials on nerve growth factor
January 22, 2019 - Dry Mouth and Older Adults: Information for Caregivers
January 22, 2019 - Are your grandparents getting tipsy at the holiday party?
January 22, 2019 - New machine learning algorithms identify early symptoms of urinary tract infections
January 22, 2019 - Young women skipping the Pap smear test due to embarrassment
January 22, 2019 - A global influenza pandemic high on the WHO’s agenda
January 22, 2019 - Amgen Makes All Repatha (evolocumab) Device Options Available In The US At A 60 Percent Reduced List Price
January 22, 2019 - Elastronics—hydrogel-based microelectronics for localized low-voltage neuromodulation
January 22, 2019 - Branched-chain amino acids in tumors can be targeted to prevent and treat cancer
January 22, 2019 - Fueling macrophages with energy to attack and eat cancer cells
January 22, 2019 - Amgen And UCB Receive Positive Vote From FDA Advisory Committee In Favor Of Approval For Evenity (romosozumab)
January 22, 2019 - Does being bilingual make children more focused? Study says no
January 22, 2019 - Study reveals new genes and biological pathways linked to osteoarthritis
January 22, 2019 - FSU study provides better understanding of spinal cord injuries
January 22, 2019 - Delaying bath for newborn babies increases breastfeeding rates, finds study
January 21, 2019 - WHO identifies non-communicable diseases as major threat to human health
January 21, 2019 - Many parents still try non-evidence-based cold prevention methods for children
January 21, 2019 - High Levels of Activity, Motor Ability Linked to Better Cognition
January 21, 2019 - Killer blows? Knockout study of pair of mouse MicroRNA provides cancer insight
January 21, 2019 - Buffalo researchers receive grant to quicken development of generic equivalents of contraceptives
January 21, 2019 - One-third of pregnant women do not believe cannabis is harmful to their fetus
January 21, 2019 - Fiderstat could be used as chemopreventative drug for intestinal cancers caused by APC gene mutations
January 21, 2019 - Modifying healthcare delivery practices may improve discussions between youth and healthcare providers
January 21, 2019 - UNIST researcher named as recipient of Merck’s 2018 Life Science Awards
January 21, 2019 - How Getting a Flu Shot Could Save Your Life
January 21, 2019 - Surgical adhesions can be treated, prevented in mice
January 21, 2019 - Increased physician-targeted marketing associated with higher opioid overdose deaths
January 21, 2019 - Researchers uncover specific microbial signatures of intestinal disease
January 21, 2019 - Researchers discover new blood vessel system in bones
January 21, 2019 - Simple blood test reliably detects signs of Alzheimer’s damage before symptoms
January 21, 2019 - Study to investigate new targeted oral treatments for severe asthma
January 21, 2019 - Plan Your Plate | NIH News in Health
January 21, 2019 - Fecal occult blood test may improve CRC outcomes in some
January 21, 2019 - Blood test detects Alzheimer’s disease years before symptoms develop
January 21, 2019 - Mount Sinai joins with Paradigm and ReqMed to repurpose drug for treatment of MPS
January 21, 2019 - FDA Advisory Committee Votes on Zynquista (sotagliflozin) as Treatment for Adults with Type 1 Diabetes
January 21, 2019 - The causes and complications of snoring
January 21, 2019 - Placenta adapts and compensates when pregnant mothers have poor diets or low oxygen
January 21, 2019 - New implant could restore the transmission of electrical signals in injured central nervous system
January 21, 2019 - Rapid-acting fentanyl test strips found to be effective at reducing overdose risk
January 21, 2019 - Coronary Artery Calcium May Help Predict CVD in South Asians
January 21, 2019 - The mystery of the super-ager
January 21, 2019 - Scientists develop smart microrobots that can change shape depending on their surroundings
January 21, 2019 - Keep Moving to Keep Brain Sharp in Old Age
January 21, 2019 - Despite progress, gay fathers and their children still structurally stigmatized
January 21, 2019 - New drug for treating liver parasites in vivax malaria
January 21, 2019 - Merck recognized with 2018 Life Science Industry Award for best use of social media
January 21, 2019 - Coeur Wallis equips the canton of Valais with 260 SCHILLER defibrillators
January 21, 2019 - Scientists propose quick and pain-free method for diagnosing kidney cancer
January 21, 2019 - Signs of memory loss could point to hearing issues
January 21, 2019 - HeartFlow Analysis shows highest diagnostic performance for detecting coronary artery disease
January 21, 2019 - How Much Caffeine is Too Much?
January 21, 2019 - Take a timeout before you force your child to apologize
January 21, 2019 - Scientists design two AI algorithms to improve early detection of cognitive impairment
January 21, 2019 - Novel therapy for children with chronic hormone deficiency provides lifeline for parents
January 21, 2019 - Bioethicists call for oversight of poorly regulated, consumer-grade neurotechnology products
January 21, 2019 - Study shows hereditary hemochromatosis behind many cancers and joint diseases
January 21, 2019 - Short bouts of stairclimbing throughout the day can improve cardiovascular health
January 20, 2019 - Liver Transplant Survival May Improve With Race Matching
January 20, 2019 - Study implicates hyperactive immune system in aging brain disorders
January 20, 2019 - Cancer Diagnosis May Quadruple Suicide Risk
January 20, 2019 - Parkinson’s disease experts devise a roadmap
January 20, 2019 - Research brings new hope to treating degenerative brain diseases
January 20, 2019 - Scientists pinpoint a set of molecules that wire the body weight center of the brain
January 20, 2019 - Researchers get close to developing elusive blood test for Alzheimer’s disease
January 20, 2019 - UCLA researchers demonstrate new technique to develop cancer-fighting T cells
January 20, 2019 - Researchers discover how cancer cells avoid genetic meltdown
January 20, 2019 - Exercise makes even the ‘still overweight’ healthier: study
January 20, 2019 - University of Utah to establish first-of-its-kind dark sky studies minor in the US
Journalist examines OxyContin’s role in opioid crisis

Journalist examines OxyContin’s role in opioid crisis

image_pdfDownload PDFimage_print

Most reporters don’t go into work thinking they’re going to find a story that will occupy them for 17 years.

But that’s what happened to Barry Meier.

In 2001, a person serving on the board regulating Ohio’s pharmacies called an editor at The New York Times to sound the alarm about a drug that appeared to be highly addictive despite company claims that it was resistant to abuse. The editor passed the tip to Meier, who began reporting his first story about OxyContin, a prescription narcotic manufactured by Purdue Pharma.

“I had no idea what a narcotic is. I had no idea what a painkiller is,” Meier said. He picked up the phone and started making calls.

Those phone calls planted the seeds for newspaper reports — and then a book — on the tangled business, medical and law enforcement dynamics of what would balloon into a national crisis of addiction, overdose and crime related to opioids. Published in 2003, the book, Pain Killer, was updated and expanded earlier this year.

Meier recently discussed the complex journey with Paul Costello, Stanford School of Medicine’s chief communications officer, at a recent Health Policy Forum.

“I had no idea this would become the catastrophe — or the scope of the catastrophe — that it’s become,” Meier told the audience. He added:

It’s very disheartening in many ways to see, not just what I wrote about… but all the other warning signs that were driven through, all the other yellow lights that were missed, all the red lights and stop signs that were ignored, by not just drug companies, but by doctors, by public health officials, by lawmakers, by the justice department.

Doctors and drug companies had good intentions when they began looking for better treatment options for patients with chronic pain from non-terminal conditions, such as arthritis and headaches, Meier said. Arriving on the market in 1996, OxyContin appeared to fill that need. Purdue claimed patients taking a moderate dose for long periods of time would not experience withdrawal when they stopped using the narcotic painkiller without tapering off, and that the time-released formula was less subject to abuse.

That was not the case. What’s more, Meier’s reporting for the Times and his book indicates that Purdue executives were aware of OxyContin’s potential for abuse in early years, but did not inform others.

The company admitted misleading marketing tactics for OxyContin in 2007, when Purdue’s parent company pleaded guilty to a federal criminal charge of misbranding the drug and agreed to pay $600 million in penalties. Additionally, three men who had served as top executives for the company each pleaded guilty to individual misdemeanor charges.

Meier told the audience that he later learned that prosecutors had originally wanted to charge the officials with felonies, but top Justice Department officials decided not to move forward with the recommendation. The prosecutors laid out the evidence for the weightier charges in a 120-page memo that Meier acquired about 18 months ago, he said. He wrote about it in a Times article published this year.

The decision not to pursue felony charges against the executives was a pivotal moment for the opioid crisis, Meier told the audience at Stanford:

Had this prosecution gone forward, had this trial gone forward — even if these executives had been found innocent during this trial — the evidence that these prosecutors would have brought to public awareness, to the awareness of doctors, public health officials, legislators, whomever, during the course of this trial would have been an awakening.

Now, Purdue Pharma faces numerous lawsuits from state and local governments, accusing the company of fueling the opioid epidemic through deceptive marketing of OxyContin. The Sackler family, billionaires who own the company, has been named in some of the suits.

While Meier acknowledged the importance of monetary compensation to defray the cost of medical treatment for people who are addicted, he said he hopes the lawsuits are not settled:

The thing that is most important right now, the thing that is going to have the most lasting effect on how medicine is practiced in the future and how public policy is practiced in the future is to have the entire truth of what these companies knew, how they behaved and the steps that they failed to take be made public.

There should be a final public accounting for the hundreds of thousands of lives that have been lost over the last 15 years.

Photo by PhotoLizM

Tagged with:

About author

Related Articles